What Agilent Technologies Does & How It Makes Money (A)
Updated October 2026 · reflects Agilent Technologies's latest reported financials
Maker of lab instruments, software, and services for life sciences and chemistry. Agilent sells analytical instruments such as chromatography, mass spectrometry, and spectroscopy systems, and then earns recurring revenue from consumables, software, and services like repairs, maintenance, and compliance support for its installed base.

How Agilent Technologies makes money
Agilent sells analytical instruments such as chromatography, mass spectrometry, and spectroscopy systems, and then earns recurring revenue from consumables, software, and services like repairs, maintenance, and compliance support for its installed base. It sells through direct sales, distributors, resellers, representatives, and e-commerce.
What Agilent Technologies does
Agilent Technologies provides instruments, software, consumables, and services to labs in the life sciences, diagnostics, and applied chemical markets. It has three segments. Life Sciences and Diagnostics Markets covers liquid chromatography and LC mass spectrometry systems, plus genomics, pathology, companion diagnostics, biomolecular analysis, and contract development and manufacturing (CDMO). Applied Markets offers gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. The Agilent CrossLab segment is the recurring-revenue side of the business. It sells columns, sample preparation products, custom chemistries, and lab supplies, along with software such as the OpenLab platform and informatics for instrument control, data analysis, and lab workflow management. It also provides repairs, maintenance, training, compliance support, and consulting. Agilent was incorporated in 1999 and is headquartered in Santa Clara, California.
Products & services
- Liquid chromatography and LC mass spectrometry systems
- Gas chromatography and spectroscopy instruments
- Agilent CrossLab services and consumables
- OpenLab laboratory software
- Pathology and companion diagnostics
- Automated sample preparation and liquid handling
What is Agilent Technologies worth?
On an owner-earnings DCF, Agilent Technologies's most-likely value is about $110 versus a recent price near $171 (36% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$52) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Danaher (DHR) · Thermo Fisher Scientific (TMO) · Waters (WAT) · Avantor (AVTR) · Bio-Techne (TECH)
TacticScale